etidronate has been researched along with Deficiency, Vitamin D in 12 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
| Excerpt | Relevance | Reference |
|---|---|---|
| "No publications have reported on osteomalacia in patients receiving intermittent cyclical therapy with etidronate (a bisphosphonate) and undergoing long-term hemodialysis (HD)." | 4.02 | Case report: Osteomalacia due to bisphosphonate treatment in a patient on hemodialysis. ( Hatano, M; Hirota, Y; Hoshino, J; Isawa, K; Kitajima, I; Nakamura, M; Sawa, N; Ubara, Y; Yamamoto, S, 2021) |
| "Patients were eligible for inclusion if they had osteoporosis or osteopenia and demonstrated a decline in BMD during the preceding year while taking stable doses of alendronate or risedronate, plus supplemental calcium and vitamin D." | 3.74 | Increase in bone mass after correction of vitamin D insufficiency in bisphosphonate-treated patients. ( Adams, JS; Geller, JL; Hu, B; Mirocha, J; Reed, S, 2008) |
| "The effects of vitamin D deficiency in osteopenic postmenopausal women treated with intermittent cyclical etidronate have been studied." | 3.69 | Diminished effect of etidronate in vitamin D deficient osteopenic postmenopausal women. ( Hackeng, WH; Koster, JC; Mulder, H, 1996) |
| "Urinary deoxypyridinoline, a bone resorption marker, decreased by 46." | 2.73 | Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease. ( Honda, Y; Iwamoto, J; Sato, Y, 2007) |
| "Treatment with menatetrenone, risedronate or regular sunlight exposure are safe and effective in increasing bone mass and reducing the risk of hip fracture in patients with AD." | 2.46 | [Dementia and fracture]. ( Sato, Y, 2010) |
| "We studied 1515 women with postmenopausal osteoporosis under treatment with anti-resorbing agents (alendronate, risedronate, raloxifene) for 13." | 1.35 | Vitamin D status and response to treatment in post-menopausal osteoporosis. ( Adami, S; Bianchi, G; Di Munno, O; Fiore, CE; Giannini, S; Minisola, S; Rossini, M; Sinigaglia, L, 2009) |
| "Vitamin D deficiency was characterized by an increase in proliferating cells, with a relative paucity of hypertrophic cells; EHDP treatment was characterized by an increase in hypertrophic cells." | 1.25 | The comparative effects of vitamin d deficiency and ethane-1-hydroxy-1,1-diphosphonate administration on the histology and glycolysis of chick epiphyseal and articular cartilage. ( Bisaz, S; Fleisch, H; Kunin, AS; Mühlbauer, R; Russell, RG; Schenk, R, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (33.33) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hatano, M | 1 |
| Kitajima, I | 1 |
| Yamamoto, S | 1 |
| Nakamura, M | 1 |
| Isawa, K | 1 |
| Hirota, Y | 1 |
| Hoshino, J | 1 |
| Sawa, N | 1 |
| Ubara, Y | 1 |
| Adami, S | 1 |
| Giannini, S | 1 |
| Bianchi, G | 1 |
| Sinigaglia, L | 1 |
| Di Munno, O | 1 |
| Fiore, CE | 1 |
| Minisola, S | 1 |
| Rossini, M | 1 |
| Sato, Y | 2 |
| Hamdy, RC | 1 |
| Chesnut, CH | 1 |
| Gass, ML | 1 |
| Holick, MF | 1 |
| Leib, ES | 1 |
| Lewiecki, ME | 1 |
| Maricic, M | 1 |
| Watts, NB | 1 |
| Honda, Y | 1 |
| Iwamoto, J | 1 |
| Fratzl, P | 1 |
| Roschger, P | 1 |
| Fratzl-Zelman, N | 1 |
| Paschalis, EP | 1 |
| Phipps, R | 1 |
| Klaushofer, K | 1 |
| Geller, JL | 1 |
| Hu, B | 1 |
| Reed, S | 1 |
| Mirocha, J | 1 |
| Adams, JS | 1 |
| Koster, JC | 1 |
| Hackeng, WH | 1 |
| Mulder, H | 1 |
| Pointon, JJ | 1 |
| Francis, MJ | 1 |
| Smith, R | 1 |
| Taylor, CM | 1 |
| Mawer, EB | 1 |
| Reeve, A | 1 |
| Bisaz, S | 1 |
| Schenk, R | 1 |
| Kunin, AS | 1 |
| Russell, RG | 1 |
| Mühlbauer, R | 1 |
| Fleisch, H | 1 |
| Baxter, LA | 1 |
| Deluca, HF | 1 |
| Bonjour, JP | 1 |
| Fleisch, HA | 1 |
2 reviews available for etidronate and Deficiency, Vitamin D
| Article | Year |
|---|---|
[Dementia and fracture].
Topics: Accidental Falls; Bone Density; Dementia; Etidronic Acid; Hip Fractures; Humans; Hyperparathyroidism | 2010 |
Review of treatment modalities for postmenopausal osteoporosis.
Topics: Alendronate; Bone Density; Bone Density Conservation Agents; Calcium; Combined Modality Therapy; Die | 2005 |
1 trial available for etidronate and Deficiency, Vitamin D
| Article | Year |
|---|---|
Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease.
Topics: Aged; Aged, 80 and over; Amino Acids; Biomarkers; Bone Density; Bone Density Conservation Agents; Bo | 2007 |
9 other studies available for etidronate and Deficiency, Vitamin D
| Article | Year |
|---|---|
Case report: Osteomalacia due to bisphosphonate treatment in a patient on hemodialysis.
Topics: Bone and Bones; Bone Density Conservation Agents; Calcitriol; Cholecalciferol; Etidronic Acid; Human | 2021 |
Vitamin D status and response to treatment in post-menopausal osteoporosis.
Topics: Activities of Daily Living; Aged; Alendronate; Biomarkers; Bone Density; Bone Density Conservation A | 2009 |
Evidence that treatment with risedronate in women with postmenopausal osteoporosis affects bone mineralization and bone volume.
Topics: Absorptiometry, Photon; Aged; Biopsy; Bone and Bones; Bone Density Conservation Agents; Bone Remodel | 2007 |
Increase in bone mass after correction of vitamin D insufficiency in bisphosphonate-treated patients.
Topics: Absorptiometry, Photon; Adult; Aged; Aged, 80 and over; Alendronate; Bone Density; Bone Density Cons | 2008 |
Diminished effect of etidronate in vitamin D deficient osteopenic postmenopausal women.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Alkaline Phosphatase; Bone Density; Calcium; Creati | 1996 |
Effect of vitamin D deficiency on sarcoplasmic reticulum function and troponin C concentration of rabbit skeletal muscle.
Topics: Animals; Body Weight; Bone and Bones; Calcium; Etidronic Acid; Male; Muscle Proteins; Muscles; Phosp | 1979 |
The effects of a diphosphonate and dietary calcium on the metabolism of vitamin D3 (cholecalciferol) in the chick.
Topics: Animals; Calcium; Calcium, Dietary; Chickens; Cholecalciferol; Dihydroxycholecalciferols; Etidronic | 1975 |
The comparative effects of vitamin d deficiency and ethane-1-hydroxy-1,1-diphosphonate administration on the histology and glycolysis of chick epiphyseal and articular cartilage.
Topics: Animals; Calcification, Physiologic; Calcium; Cartilage; Cartilage, Articular; Cell Differentiation; | 1975 |
Inhibition of vitamin D metabolism by ethane-1-hydroxyl-1, 1-diphosphonate.
Topics: Animals; Bone and Bones; Calcium; Chickens; Cholecalciferol; Duodenum; Etidronic Acid; Hydroxycholec | 1974 |